Holdings
37
Concentrated
Top 10 weight
54%
Concentration
Active share
-
Style
Equity
97%
Asset allocation
Portfolio
-Sectors
6High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap29%
Mid cap29%
Small cap39%
Asset allocation
Equity97%
Top holdings
10.0%
Divis Laboratories Ltd.EQUITY
7.2%5.6%
Lupin Ltd.EQUITY
5.3%Cipla Ltd.EQUITY
5.2%5.1%
4.6%
Alkem Laboratories Ltd.EQUITY
4.0%3.8%
Ipca Laboratories Ltd.EQUITY
3.5%TREPS - Tri-party RepoCASH_EQUIVALENT
3.3%3.2%
Global Health LimitedEQUITY
3.1%2.9%
2.9%
2.5%
Shilpa Medicare LtdEQUITY
2.5%2.3%
2.2%
Wockhardt Ltd.EQUITY
2.1%1.7%
Rubicon Research LimitedEQUITY
1.7%1.5%
Eris Lifesciences LtdEQUITY
1.5%Ajanta Pharma LimitedEQUITY
1.4%CORONA REMEDIES LIMITEDEQUITY
1.3%Gland Pharma Ltd.EQUITY
1.2%1.2%
Biocon Ltd.EQUITY
1.2%1.0%
BAJAJ HEALTHCARE LIMITEDEQUITY
0.8%Laxmi Dental LimitedEQUITY
0.6%Novartis India Ltd.EQUITY
0.5%0.4%
0.3%
Net Current AssetsCASH_EQUIVALENT
-0.6%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- Small-cap heavy (39%) - higher volatility.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
70.2%
26.5%
0.6%